We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$188M
AUM Growth
+$30.7M
Cap. Flow
+$18.4M
Cap. Flow %
9.8%
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73

Top Buys

Rank Stock Value
1
TCPC icon
BlackRock TCP Capital
TCPC
+$1.06M
2
HST icon
Host Hotels & Resorts
HST
+$965K
3
PLTR icon
Palantir
PLTR
+$932K
4
PSA icon
Public Storage
PSA
+$920K
5
DFS
Discover Financial Services
DFS
+$865K

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$962K
2
PLD icon
Prologis
PLD
+$773K
3
BKNG icon
Booking.com
BKNG
+$734K
4
ETN icon
Eaton
ETN
+$720K
5
TEL icon
TE Connectivity
TEL
+$708K

Sector Composition

Rank Sector Weight
1 Healthcare 21.52%
2 Financials 20.16%
3 Technology 16.46%
4 Industrials 8.76%
5 Energy 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INBX
351
DELISTED
Inhibrx, Inc. Common Stock
INBX
$110K 0.06%
3,143
-219
-7% -$7.99K
ITOS
352
DELISTED
iTeos Therapeutics
ITOS
$110K 0.06%
8,046
-550
-6% -$5.99K
ARDX icon
353
Ardelyx
ARDX
$1.24B
$109K 0.06%
14,940
-1,022
-6% -$8.74K
RVMD icon
354
Revolution Medicines
RVMD
$38.5B
$107K 0.06%
3,311
-229
-6% -$6.79K
ARCT icon
355
Arcturus Therapeutics
ARCT
$165M
$104K 0.06%
3,087
-215
-7% -$7.62K
SNDX icon
356
Syndax Pharmaceuticals
SNDX
$1.7B
$104K 0.06%
4,359
-298
-6% -$6.65K
MORF
357
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$103K 0.05%
2,935
-198
-6% -$6.64K
PHAT icon
358
Phathom Pharmaceuticals
PHAT
$928M
$103K 0.05%
9,701
-666
-6% -$5.66K
ANAB icon
359
AnaptysBio
ANAB
$1.54B
$102K 0.05%
4,551
-311
-6% -$7.36K
ZYME icon
360
Zymeworks
ZYME
$1.62B
$101K 0.05%
9,605
-659
-6% -$7.32K
CLDX icon
361
Celldex Therapeutics
CLDX
$2.94B
$101K 0.05%
2,399
-162
-6% -$6.65K
DAWN
362
DELISTED
Day One Biopharmaceuticals
DAWN
$100K 0.05%
6,078
-414
-6% -$6.2K
ARVN icon
363
Arvinas
ARVN
$530M
$100K 0.05%
2,431
-164
-6% -$7.17K
PGEN icon
364
Precigen
PGEN
$1.94B
$99.7K 0.05%
68,764
-4,713
-6% -$6.77K
SLNO
365
DELISTED
Soleno Therapeutics
SLNO
$99.6K 0.05%
2,327
-163
-7% -$7.37K
MDGL icon
366
Madrigal Pharmaceuticals
MDGL
$12.6B
$98.3K 0.05%
368
-29
-7% -$6.83K
AKRO
367
DELISTED
Akero Therapeutics
AKRO
$98K 0.05%
3,879
-269
-6% -$6.46K
PCVX icon
368
Vaxcyte
PCVX
$7.65B
$97.8K 0.05%
1,432
-96
-6% -$6.65K
BEAM icon
369
Beam Therapeutics
BEAM
$2.68B
$96.2K 0.05%
2,911
-197
-6% -$6.14K
LYEL icon
370
Lyell Immunopharma
LYEL
$318M
$95.6K 0.05%
2,145
-147
-6% -$6.29K
ETNB
371
DELISTED
89bio
ETNB
$93.6K 0.05%
8,038
-550
-6% -$6.09K
CMPS
372
Compass Pathways
CMPS
$1.47B
$93.4K 0.05%
11,221
-771
-6% -$7.77K
IMTX icon
373
Immatics
IMTX
$1.23B
$92.9K 0.05%
8,837
-610
-6% -$7.11K
RCUS icon
374
Arcus Biosciences
RCUS
$3.33B
$92.7K 0.05%
4,911
-340
-6% -$5.88K
IRON icon
375
Disc Medicine
IRON
$2.81B
$92.6K 0.05%
1,488
-101
-6% -$6.55K
13 14
15
16 17

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Virtus ETF Advisers held 495 positions worth $188M, up 19% from $158M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $18.4M of net new capital in Q1 2024, opening 69 new positions and adding to 189 existing holdings. Its largest new stake was Host Hotels & Resorts: 47,997 shares worth $993K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was ConocoPhillips, an estimated $569K trimmed.

  • Virtus ETF Advisers's largest Q1 2024 buy was Host Hotels & Resorts: 47,997 shares worth $993K.
  • Virtus ETF Advisers added most to BlackRock TCP Capital in Q1 2024, an estimated $1.06M increase.
  • Virtus ETF Advisers's biggest Q1 2024 reduction was ConocoPhillips, cutting an estimated $569K.
  • Virtus ETF Advisers fully exited Burlington in Q1 2024, selling an estimated $962K.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $188M portfolio in Q1 2024.
  • Virtus ETF Advisers opened 69 new positions and closed 73 in Q1 2024.
  • Virtus ETF Advisers's portfolio value rose 19% quarter-over-quarter to $188M.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.